Phase 1 Study of 68Ga-R8760

Status:
Recruiting

Trial end date:
2024-04-01

Target enrollment:

Participant gender:

A Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients with Adrenocortical Carcinoma and Healthy Volunteers

Phase 1

Radionetics Oncology